-
MDA Ambassador Guest Blog: How My MG Journey Has Shaped Who I Am Today
Courtney B. is a passionate advocate for living life to the fullest despite the challenges […]
-
Why those of us with FSHD feel like we’re always in transition
During a recent facioscapulohumeral muscular dystrophy (FSHD) wellness group meeting via Zoom, we each shared […]
-
PepGen ends development of Duchenne Exon-51 skipping program
PepGen has ended clinical trials of PGN-EDO51, their investigational therapy for Duchenne patients amenable to skipping exon […]
-
A day of reflection leads me to a place of gratitude as a DMD mom
Once again, I’m writing from an uncomfortable chair in an infusion room as my son […]
-
My Father’s Journey with ALS
Father’s Day can be a beautiful celebration — but also a tender time for many. […]
-
Accessible Air Travel Is Ready for Takeoff. Can It Avoid Turbulence?
The past year featured the most disability-positive changes for air travel in decades. While there […]
-
Simply Stated: Updates in Ryanodine Receptor 1-Related Disorders (RYR-1-RD)
RYR-1-Related Disorders (RYR-1-RD) are a group of rare, inherited muscle disorders caused by variants in the […]
-
PepGen Announces Discontinuation of PGN-EDO51 Development
We are disappointed to share that PepGen Inc. announced the company’s decision to end development […]
-
CureDuchenne invests in new redosable DMD gene therapy
CureDuchenne is investing $1 million in Entos Pharmaceuticals to support the development of a new […]
-
Governor Abbott Signs Duchenne Newborn Screening into Law in Texas
We are pleased to share a significant milestone for the Duchenne community: Texas Governor Greg […]
